T1	Participants 311 352	men with locally advanced prostate cancer
T2	Participants 568 614	patients with locally advanced prostate cancer
T3	Participants 616 677	Patients with T3-4, N0/Nx, M0 prostate cancer or T1-2 disease
T4	Participants 1051 1089	One thousand two hundred five patients
